Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News GRI Bio, Vallon Pharmaceuticals to merge for advancing NKT cell regulators GRI Bio, a privately held clinical stage biotech company, will merge with a wholly-owned subsidiary of Nasdaq-listed Vallon… byRaghuram KadariDecember 15, 2022